EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function

Julia M Hartman iD, Kobe Ikegami iD, Marina Provenzano iD, Kameron Bates iD, Amanda Butler iD, Aileen S Jones iD, Kiera N Berggren iD, Jeanne Dekdebrun, Marnee J McKay, Jennifer N Baldwin iD, Kayla M D Cornett iD, Joshua Burns iD und 4 weitere

Annals of Clinical and Translational Neurology · 2024-12 · 11 (12) · 3175-3191

DOI: 10.1002/acn3.52224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 25.10.2024. Verfasst von Julia M Hartman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Virginia Commonwealth University, Richmond, Virginia, 23298, USA. Hauptthemen laut MEDLINE: Myotonic Dystrophy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Takeda Pharmaceutical Company, Novartis Pharmaceuticals Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Dysregulated RNA alternative splicing is the hallmark of myotonic dystrophy type 1 (DM1). However, the association between RNA mis‐splicing and physical function in children with the most severe form of disease, congenital myotonic dystrophy (CDM), is unknown.

Methods

Eighty‐two participants (42 adults with DM1 and 40 children with CDM) with muscle biopsies and measures of myotonia, motor function, and strength were combined from five observational studies. Data were normalized and correlated with an aggregate measure of alternative splicing dysregulation, [MBNL] inferred , in skeletal muscle biopsies. Multiple linear regression analysis was performed to predict [MBNL] inferred using clinical outcome measures alone. Similar analyses were performed to predict 12‐month physical function using baseline metrics.

Results

Myotonia (measured via vHOT) was significantly correlated with RNA mis‐splicing in our cross‐sectional population of all DM1 individuals; CDM participants alone displayed no myotonia despite a similar range of RNA mis‐splicing. Measures of motor performance and muscle strength were significantly associated with [MBNL] inferred in our cohort of all DM1 individuals and when assessing children with CDM independently. Multiple linear regression analyses yielded two models capable of predicting [MBNL] inferred from select clinical outcome assessments alone in all subjects (adjusted R 2 = 0.6723) or exclusively in children with CDM (adjusted R 2 = 0.5875).

Interpretation

Our findings establish significant correlations between skeletal muscle performance and a composite measure of alternative splicing dysregulation, [MBNL] inferred , in DM1. The strength of these correlations and the development of predictive models will assist in designing efficacious clinical trials for individuals with DM1, particularly CDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyHumansMaleChildFemaleAdultAdolescentMuscle, SkeletalMuscle StrengthCross-Sectional StudiesChild, PreschoolYoung AdultMiddle AgedAlternative SplicingRNA Splicing

Autor:innen und Institutionen

  • Medical Scientist Training Program, Virginia Commonwealth University, Richmond, Virginia, 23298, USA.
  • Center for Inherited Myology Research, Virginia Commonwealth University, Richmond, Virginia, 23298, USA.
  • Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, 23298, USA.
  • Department for Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia, 23298, USA.
  • Children's Hospital of Richmond at Virginia Commonwealth University, Pediatric Therapy Services, Richmond, Virginia, 23220, USA.
  • Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA.

ORCID-Profile: Julia M Hartman, Kobe Ikegami, Marina Provenzano, Kameron Bates, Amanda Butler, Aileen S Jones, Kiera N Berggren, Jennifer N Baldwin, Kayla M D Cornett, Joshua Burns, Michael Kiefer, Nicholas E Johnson, Melissa A Hale

Förderung

  • NINDS NIH HHS
  • Takeda Pharmaceutical Company
  • Novartis Pharmaceuticals Corporation
  • Avidity Biosciences
  • PepGen
  • Muscular Dystrophy Association
  • FDA HHS
  • Dyne Therapeutics

Zitieren

APA

Hartman, J. M., Ikegami, K., Provenzano, M., Bates, K., Butler, A., Jones, A. S., Berggren, K. N., Dekdebrun, J., McKay, M. J., Baldwin, J. N., Cornett, K. M. D., Burns, J., Kiefer, M., Johnson, N. E., Hale, M. A., & DMCRN Consortium (2024). RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function. Annals of Clinical and Translational Neurology, 11(12), 3175-3191. https://doi.org/10.1002/acn3.52224

Vancouver

Hartman JM, Ikegami K, Provenzano M, Bates K, Butler A, Jones AS, et al. RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function. Annals of Clinical and Translational Neurology. 2024;11(12):3175-3191. doi:10.1002/acn3.52224

BibTeX
@article{Hartman2024,
  author = {Hartman, Julia M and Ikegami, Kobe and Provenzano, Marina and Bates, Kameron and Butler, Amanda and Jones, Aileen S and Berggren, Kiera N and Dekdebrun, Jeanne and McKay, Marnee J and Baldwin, Jennifer N and Cornett, Kayla M D and Burns, Joshua and Kiefer, Michael and Johnson, Nicholas E and Hale, Melissa A and DMCRN Consortium, DMCRN Consortium},
  title = {RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {12},
  pages = {3175--3191},
  doi = {10.1002/acn3.52224}
}
Kostenlos starten →